Myeloma Bone Disease

被引：1

作者：

Sanderson, Ralph D. ^{[1
,2
]}

Epstein, Joshua ^{[3
]}

机构：

[1] Univ Alabama Birmingham, Dept Pathol, Ctr Metab Bone Dis, Birmingham, AL 35294 USA

[2] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA

[3] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Dept Med, Little Rock, AR 72205 USA

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2009年 / 24卷 / 11期

关键词：

KAPPA-B LIGAND; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; CARBOXY-TERMINAL TELOPEPTIDE; SOLUBLE RECEPTOR ACTIVATOR; I COLLAGEN ICTP; MULTIPLE-MYELOMA; BIOCHEMICAL MARKERS; OSTEOBLAST DIFFERENTIATION; MARROW MICROENVIRONMENT; GROWTH-FACTOR;

D O I：

10.1359/JBMR.090901

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1783 / 1788

页数：6

共 50 条

[1] Myeloma and Bone Disease
Cristina Panaroni
Andrew J. Yee
Noopur S. Raje
Current Osteoporosis Reports, 2017, 15 : 483 - 498
[2] Myeloma bone disease
Matsumoto, T.
BONE, 2011, 48 : S57 - S58
[3] Myeloma and Bone Disease
Panaroni, Cristina
Yee, Andrew J.
Raje, Noopur S.
CURRENT OSTEOPOROSIS REPORTS, 2017, 15 (05) : 483 - 498
[4] Bone disease in myeloma
Berenson J.R.
Current Treatment Options in Oncology, 2001, 2 (3) : 271 - 283
[5] Myeloma bone disease
Callander, NS
Roodman, GD
SEMINARS IN HEMATOLOGY, 2001, 38 (03) : 276 - 285
[6] Myeloma bone disease
Sezer, O
HEMATOLOGY, 2005, 10 : 19 - 24
[7] Myeloma bone disease
Berenson, JR
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (04) : 653 - 672
[8] Myeloma bone disease
Mundy, GR
EUROPEAN JOURNAL OF CANCER, 1998, 34 (02) : 246 - 251
[9] Myeloma-bone interaction for the development of myeloma bone disease
Matsumoto, T
Kido, S
Inoue, D
Oshima, T
Abe, M
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1566 - 1566
[10] Pathophysiology of myeloma bone disease
Esteve, Flavia R.
Roodman, G. David
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 613 - 624

← 1 2 3 4 5 →